Cite
HARVARD Citation
Zheng, Y. et al. (2018). Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients With Urothelial Carcinoma. Clinical pharmacology & therapeutics. 103 (4), pp. 643-652. [Online].